Gastrointestinal Cancer Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MORF | C | Morphic Holding, Inc. | 1.76 | |
PMCB | F | PharmaCyte Biotech, Inc. | -2.43 | |
RNXT | F | RenovoRx, Inc. | -0.88 | |
PBLA | F | Panbela Therapeutics, Inc. | 0.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.29 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.09 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.4 | |
XBI | C | SPDR S&P Biotech ETF | 0.35 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 0.23 |
Compare ETFs
- Gastrointestinal Cancer
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other associated problems. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis.
Overall, the GI tract and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancers and more deaths from cancer than any other system in the body. There is significant geographic variation in the rates of different gastrointestinal cancers.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles